![William Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 M $ al 30/06/2026
William A. Jones is currently Director at LUNGevity Foundation since 2020, Director at Akili Interactive Labs, Inc. since 2022, Independent Director at Apogee Therapeutics, Inc. since 2023, Director at Annexon, Inc. starting 2025, and Chief Commercial Officer at NewAmsterdam Pharma Co. NV since 2023.
Formerly, Mr. Jones was Director-US Marketing at Bristol Myers Squibb Co. from 1992 to 2004, Vice President-Marketing & Business Development at NitroMed, Inc. from 2004 to 2007, Vice President-Sales at Boehringer Ingelheim Pharmaceuticals, Inc. from 2007 to 2013, Vice President & Head-Sales at AstraZeneca Pharmaceuticals LP from 2014 to 2016, VP, Head-Sales & Commercial Operations at Takeda Pharmaceuticals U.S.A., Inc. from 2016 to 2019, Chief Commercial Officer-Migraine & Common Disease at Biohaven Pharmaceutical Holding Co. Ltd. from 2019 to 2022, and Independent Director at Akili, Inc. from 2022 to 2024.
Education includes graduate studies at Texas A&M University, undergraduate studies at United States Air Force Academy, and an MBA from Stanford Graduate School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/07/2026 | 34.824 ( 0,06 % ) | 5 M $ | 30/06/2026 | |
| 07/01/2025 | 43.000 ( 0,04 % ) | 1 M $ | 30/06/2026 | |
ANNEXON, INC. -.--% | 11/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/06/2023 |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Corporate Officer/Principal | 14/08/2023 |
| ANNEXON, INC. | Director/Miembro de la Junta | 09/01/2025 |
LUNGevity Foundation
 LUNGevity Foundation Miscellaneous Commercial ServicesCommercial Services Engages in organizing awareness and fundraising for lung cancer | Director/Miembro de la Junta | 26/05/2020 |
Akili Interactive Labs, Inc.
 Akili Interactive Labs, Inc. Information Technology ServicesTechnology Services Develops digital treatments and care solutions for people affected by cognitive impairments | Director/Miembro de la Junta | 18/08/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| AKILI, INC. | Director/Miembro de la Junta | 02/07/2024 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | 01/12/2022 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Ventas & Marketing | 01/03/2019 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Ventas & Marketing | 01/12/2016 |
| ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 15 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
United States Air Force Academy
 United States Air Force Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
LUNGevity Foundation
LUNGevity Foundation Miscellaneous Commercial ServicesCommercial Services Engages in organizing awareness and fundraising for lung cancer | Commercial Services |
Akili Interactive Labs, Inc.
Akili Interactive Labs, Inc. Information Technology ServicesTechnology Services Develops digital treatments and care solutions for people affected by cognitive impairments | Technology Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Akili, Inc.
 Akili, Inc. Medical SpecialtiesHealth Technology Operates as a digital medicine company that uses video-game technology and neuroscience to create treatments for cognitive conditions | Health Technology |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
